If it is a cheap placement to Patos now at the lows when they dont really need cash then this management are pretty poor at managing their stock and adding value because it just makes no sense to raise money now at a discount and to someone like Patersons who arent a strategic investor when it just isnt needed
Let the 2 funded trials run and get some proper support and coverage
They are headed to the Roth US conference we could see some significant interest from US investors possibly if they present their story well
PTX Price at posting:
9.7¢ Sentiment: None Disclosure: Held
